ZymoGenetics lists IPO on Nasdaq first biotechnology company to go public in 2002.

0 Comments | M2 Presswire, February, 2002

M2 PRESSWIRE-1 February 2002-NASDAQ: ZymoGenetics lists IPO on Nasdaq first biotechnology company to go public in 2002 (C)1994-2002 M2 COMMUNICATIONS LTD RDATE:01022002 New York -- The Nasdaq Stock Market, Inc., today announced that ZymoGenetics (NASDAQ:ZGEN) listed the shares of its initial public offering and commenced trading on Nasdaq today.

The Seattle-based company, a spin-off from Danish parent, Novo Nordisk (NYSE:NVO), is the first biotechnology company to go public this year and is offering 10 million shares of its common stock for $12 per share. The lead underwriters on the transaction were Lehman Brothers and Merrill Lynch & Co. Co-lead managers were Bear, Stearns & Co. and Pacific Growth Equities. David Weild, Vice Chairman of the...